371 related articles for article (PubMed ID: 18574763)
21. [From gene to disease: amyotrophic lateral sclerosis].
van Vught PW; Veldink JH; Baas F; van Muiswinkel FL; van den Berg LH
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2125-7. PubMed ID: 15553356
[TBL] [Abstract][Full Text] [Related]
22. ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations.
Wuolikainen A; Andersen PM; Moritz T; Marklund SL; Antti H
Mol Genet Metab; 2012 Mar; 105(3):472-8. PubMed ID: 22264771
[TBL] [Abstract][Full Text] [Related]
23. Familial amyotrophic lateral sclerosis with bulbar onset and a novel Asp101Tyr Cu/Zn superoxide dismutase gene mutation.
Tan CF; Piao YS; Hayashi S; Obata H; Umeda Y; Sato M; Fukushima T; Nakano R; Tsuji S; Takahashi H
Acta Neuropathol; 2004 Oct; 108(4):332-6. PubMed ID: 15235802
[TBL] [Abstract][Full Text] [Related]
24. A novel exon 3 mutation (D76V) in the SOD1 gene associated with slowly progressive ALS.
Segovia-Silvestre T; Andreu AL; Vives-Bauza C; Garcia-Arumi E; Cervera C; Gamez J
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):69-74. PubMed ID: 12215228
[TBL] [Abstract][Full Text] [Related]
25. Superoxide dismutase--applications and relevance to human diseases.
Noor R; Mittal S; Iqbal J
Med Sci Monit; 2002 Sep; 8(9):RA210-5. PubMed ID: 12218958
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
Iłzecka J
Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
[TBL] [Abstract][Full Text] [Related]
27. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis.
Urushitani M; Ezzi SA; Julien JP
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2495-500. PubMed ID: 17277077
[TBL] [Abstract][Full Text] [Related]
29. Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis.
Tokuda E; Takei YI; Ohara S; Fujiwara N; Hozumi I; Furukawa Y
Mol Neurodegener; 2019 Nov; 14(1):42. PubMed ID: 31744522
[TBL] [Abstract][Full Text] [Related]
30. Analysis of smoking and LPO in ALS.
Anand A; Gupta PK; Prabhakar S; Sharma S; Thakur K
Neurochem Int; 2014 May; 71():47-55. PubMed ID: 24726768
[TBL] [Abstract][Full Text] [Related]
31. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
Calabrese V
Free Radic Biol Med; 2007 Jul; 43(2):160-2. PubMed ID: 17603925
[TBL] [Abstract][Full Text] [Related]
32. A novel SOD1 splice site mutation associated with familial ALS revealed by SOD activity analysis.
Birve A; Neuwirth C; Weber M; Marklund SL; Nilsson AC; Jonsson PA; Andersen PM
Hum Mol Genet; 2010 Nov; 19(21):4201-6. PubMed ID: 20709807
[TBL] [Abstract][Full Text] [Related]
33. Pyrimethamine significantly lowers cerebrospinal fluid Cu/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with SOD1 mutations.
Lange DJ; Shahbazi M; Silani V; Ludolph AC; Weishaupt JH; Ajroud-Driss S; Fields KG; Remanan R; Appel SH; Morelli C; Doretti A; Maderna L; Messina S; Weiland U; Marklund SL; Andersen PM
Ann Neurol; 2017 Jun; 81(6):837-848. PubMed ID: 28480639
[TBL] [Abstract][Full Text] [Related]
34. Role of transition metals in the pathogenesis of amyotrophic lateral sclerosis.
Vonk WI; Klomp LW
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1322-8. PubMed ID: 19021549
[TBL] [Abstract][Full Text] [Related]
35. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
[TBL] [Abstract][Full Text] [Related]
36. Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation.
Ihara Y; Nobukuni K; Takata H; Hayabara T
Neurol Res; 2005 Jan; 27(1):105-8. PubMed ID: 15829169
[TBL] [Abstract][Full Text] [Related]
37. D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype.
Parton MJ; Broom W; Andersen PM; Al-Chalabi A; Nigel Leigh P; Powell JF; Shaw CE;
Hum Mutat; 2002 Dec; 20(6):473. PubMed ID: 12442272
[TBL] [Abstract][Full Text] [Related]
38. [Superoxide dismutase in cerebrospinal fluid in patients with neurological diseases].
Yoshida E; Mokuno K; Aoki S; Takahashi A; Kato K
Rinsho Shinkeigaku; 1993 Jan; 33(1):21-6. PubMed ID: 8334770
[TBL] [Abstract][Full Text] [Related]
39. Genetic inroads in familial ALS.
Shaw PJ
Nat Genet; 2001 Oct; 29(2):103-4. PubMed ID: 11586285
[TBL] [Abstract][Full Text] [Related]
40. ALS-linked Cu/Zn-SOD mutation impairs cerebral synaptic glucose and glutamate transport and exacerbates ischemic brain injury.
Guo Z; Kindy MS; Kruman I; Mattson MP
J Cereb Blood Flow Metab; 2000 Mar; 20(3):463-8. PubMed ID: 10724110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
